Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
14601
14602
14603
14604
14605
14606
14607
14608
14609
14610
14611
14612
14613
14614
14615
14616
14617
14618
14619
14620
14621
14622
14623
14624
14625
14626
14627
14628
14629
14630
14631
14632
14633
14634
14635
14636
14637
14638
14639
14640
14641
14642
14643
14644
14645
14646
14647
14648
14649
14650
14651
14652
14653
14654
14655
14656
14657
14658
14659
14660
14661
14662
14663
14664
14665
14666
14667
14668
14669
14670
14671
14672
14673
14674
14675
14676
14677
14678
14679
14680
14681
14682
14683
14684
14685
14686
14687
14688
14689
14690
14691
14692
14693
14694
14695
14696
14697
14698
14699
14700
14701
14702
14703
14704
14705
14706
14707
14708
14709
14710
14711
14712
14713
14714
14715
14716
14717
14718
14719
14720
14721
14722
14723
14724
14725
14726
14727
14728
14729
14730
14731
14732
14733
14734
14735
14736
14737
14738
14739
14740
14741
14742
14743
14744
14745
14746
14747
14748
14749
14750
14751
14752
14753
14754
14755
14756
14757
14758
14759
14760
14761
14762
14763
14764
14765
14766
14767
14768
14769
14770
14771
14772
14773
14774
14775
14776
14777
14778
14779
14780
14781
14782
14783
14784
14785
14786
14787
14788
14789
14790
14791
14792
14793
14794
14795
14796
14797
14798
14799
14800
| UnnamedSample_HQ_transcript/3869|m.1761 | UnnamedSample_HQ_transcript/3869 | Coverage 0.073 too low. | ffa3b824af7ee5dda8beaea10fa70ce3 | 1574 | Pfam | PF00096 | Zinc finger, C2H2 type | 1356 | 1378 | 3.2E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/3869|m.1761 | UnnamedSample_HQ_transcript/3869 | Coverage 0.073 too low. | ffa3b824af7ee5dda8beaea10fa70ce3 | 1574 | Pfam | PF00096 | Zinc finger, C2H2 type | 1384 | 1408 | 0.0038 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/105165|m.23248 | UnnamedSample_HQ_transcript/105165 | Coverage 0.152 too low. | 29cb91894a9cbd8983073751f8eb76a5 | 173 | Pfam | PF17787 | PH domain | 12 | 139 | 4.6E-46 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/111006|m.23966 | UnnamedSample_HQ_transcript/111006 | Coverage 0.178 too low. | 29cb91894a9cbd8983073751f8eb76a5 | 173 | Pfam | PF17787 | PH domain | 12 | 139 | 4.6E-46 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/106538|m.23401 | UnnamedSample_HQ_transcript/106538 | Coverage 0.218 too low. | 50487596b59c3a184fdc950703113dd1 | 276 | Pfam | PF00226 | DnaJ domain | 32 | 97 | 1.7E-21 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/25119|m.8249 | UnnamedSample_HQ_transcript/25119 | Coverage 0.585 too low. | 9dc8bcb21bd68263176b7126da184c94 | 946 | Pfam | PF16134 | THO complex subunit 2 N-terminus | 439 | 572 | 1.0E-21 | T | 22-09-2020 | IPR032302 | THO complex subunit 2, N-terminal domain |
| UnnamedSample_HQ_transcript/25119|m.8249 | UnnamedSample_HQ_transcript/25119 | Coverage 0.585 too low. | 9dc8bcb21bd68263176b7126da184c94 | 946 | Pfam | PF16134 | THO complex subunit 2 N-terminus | 54 | 410 | 5.5E-49 | T | 22-09-2020 | IPR032302 | THO complex subunit 2, N-terminal domain |
| UnnamedSample_HQ_transcript/25119|m.8249 | UnnamedSample_HQ_transcript/25119 | Coverage 0.585 too low. | 9dc8bcb21bd68263176b7126da184c94 | 946 | Pfam | PF11262 | Transcription factor/nuclear export subunit protein 2 | 880 | 945 | 9.0E-12 | T | 22-09-2020 | IPR021418 | THO complex, subunitTHOC2, C-terminal |
| UnnamedSample_HQ_transcript/25119|m.8249 | UnnamedSample_HQ_transcript/25119 | Coverage 0.585 too low. | 9dc8bcb21bd68263176b7126da184c94 | 946 | Pfam | PF11732 | Transcription- and export-related complex subunit | 574 | 649 | 8.6E-24 | T | 22-09-2020 | IPR021726 | THO complex, subunitTHOC2, N-terminal |
| UnnamedSample_HQ_transcript/65209|m.17063 | UnnamedSample_HQ_transcript/65209 | Coverage 0.986 too low. | 6c6ca6209e8188c89f4fd62d8e9f3c6e | 590 | Pfam | PF00400 | WD domain, G-beta repeat | 209 | 246 | 0.0093 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/65209|m.17063 | UnnamedSample_HQ_transcript/65209 | Coverage 0.986 too low. | 6c6ca6209e8188c89f4fd62d8e9f3c6e | 590 | Pfam | PF00400 | WD domain, G-beta repeat | 388 | 417 | 0.075 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/96390|m.22156 | UnnamedSample_HQ_transcript/96390 | Coverage 0.965 too low. | 5885cfb30579b04177689a8b1a1b7103 | 370 | Pfam | PF01212 | Beta-eliminating lyase | 17 | 288 | 1.7E-81 | T | 22-09-2020 | IPR001597 | Aromatic amino acid beta-eliminating lyase/threonine aldolase |
| UnnamedSample_HQ_transcript/5133|m.2244 | UnnamedSample_HQ_transcript/5133 | Coverage 0.162 too low. | 07ada7455a1084ed30e2b9f470db7f0b | 1489 | Pfam | PF04821 | Timeless protein | 24 | 286 | 4.8E-68 | T | 22-09-2020 | IPR006906 | Timeless, N-terminal |
| UnnamedSample_HQ_transcript/5133|m.2244 | UnnamedSample_HQ_transcript/5133 | Coverage 0.162 too low. | 07ada7455a1084ed30e2b9f470db7f0b | 1489 | Pfam | PF05029 | Timeless PAB domain | 1002 | 1082 | 9.0E-21 | T | 22-09-2020 | IPR007725 | Timeless, C-terminal |
| UnnamedSample_HQ_transcript/19558|m.6743 | UnnamedSample_HQ_transcript/19558 | Coverage 0.900 too low. | c9eb1f4434723efa27be82d41886434d | 998 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 580 | 723 | 6.5E-48 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/19558|m.6743 | UnnamedSample_HQ_transcript/19558 | Coverage 0.900 too low. | c9eb1f4434723efa27be82d41886434d | 998 | Pfam | PF00204 | DNA gyrase B | 275 | 435 | 2.3E-25 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/19558|m.6743 | UnnamedSample_HQ_transcript/19558 | Coverage 0.900 too low. | c9eb1f4434723efa27be82d41886434d | 998 | Pfam | PF01751 | Toprim domain | 464 | 565 | 5.1E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/19558|m.6743 | UnnamedSample_HQ_transcript/19558 | Coverage 0.900 too low. | c9eb1f4434723efa27be82d41886434d | 998 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 725 | 997 | 5.8E-93 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/19558|m.6743 | UnnamedSample_HQ_transcript/19558 | Coverage 0.900 too low. | c9eb1f4434723efa27be82d41886434d | 998 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 88 | 232 | 1.0E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/19324|m.6677 | UnnamedSample_HQ_transcript/19324 | Identity 0.794 too low. | 5df617edd5944c492f68c09d56c8d435 | 381 | Pfam | PF00069 | Protein kinase domain | 8 | 291 | 3.3E-67 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/68450|m.17659 | UnnamedSample_HQ_transcript/68450 | Coverage 0.929 too low. | bc3de8122a1545a2c2ed91896336d34b | 400 | Pfam | PF01490 | Transmembrane amino acid transporter protein | 1 | 377 | 1.4E-55 | T | 22-09-2020 | IPR013057 | Amino acid transporter, transmembrane domain |
| UnnamedSample_HQ_transcript/19270|m.6654 | UnnamedSample_HQ_transcript/19270 | Coverage 0.985 too low. | 0b3e869ac4443c61befbcda7c5be0eff | 372 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 46 | 114 | 4.3E-13 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/19270|m.6654 | UnnamedSample_HQ_transcript/19270 | Coverage 0.985 too low. | 0b3e869ac4443c61befbcda7c5be0eff | 372 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 173 | 238 | 4.3E-13 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/19270|m.6654 | UnnamedSample_HQ_transcript/19270 | Coverage 0.985 too low. | 0b3e869ac4443c61befbcda7c5be0eff | 372 | Pfam | PF00653 | Inhibitor of Apoptosis domain | 284 | 346 | 1.2E-17 | T | 22-09-2020 | IPR001370 | BIR repeat |
| UnnamedSample_HQ_transcript/23897|m.7917 | UnnamedSample_HQ_transcript/23897 | Coverage 0.804 too low. | a62898fbf1fc6b7349ea940b7a46aa2a | 860 | Pfam | PF00096 | Zinc finger, C2H2 type | 775 | 797 | 0.0011 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/77287|m.19257 | UnnamedSample_HQ_transcript/77287 | Coverage 0.807 too low. | 193afa99404b6242aa8d41fe365a9c48 | 423 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/16989|m.6003 | UnnamedSample_HQ_transcript/16989 | Coverage 0.982 too low. | 244c72df10823ac10e788a671e54ef93 | 731 | Pfam | PF01429 | Methyl-CpG binding domain | 438 | 500 | 1.7E-8 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/95675|m.22046 | UnnamedSample_HQ_transcript/95675 | Coverage 0.158 too low. | c62d69b2d8f16009f2c64c089246b7c7 | 395 | Pfam | PF00709 | Adenylosuccinate synthetase | 1 | 392 | 9.6E-165 | T | 22-09-2020 | IPR001114 | Adenylosuccinate synthetase |
| UnnamedSample_HQ_transcript/21351|m.7236 | UnnamedSample_HQ_transcript/21351 | Unmapped. | c52da01b6353e0bf2479f206891bdba3 | 975 | Pfam | PF08762 | CRPV capsid protein like | 677 | 887 | 4.1E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/62971|m.16618 | UnnamedSample_HQ_transcript/62971 | Coverage 0.481 too low. | fdc400ba343dbffbcd00c45adc909f95 | 519 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 88 | 497 | 5.6E-94 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/19193|m.6632 | UnnamedSample_HQ_transcript/19193 | Unmapped. | e247122f31f89e2e1d48008adafa4aba | 945 | Pfam | PF08762 | CRPV capsid protein like | 673 | 883 | 3.9E-12 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/33973|m.10456 | UnnamedSample_HQ_transcript/33973 | Coverage 0.819 too low. | 8183ea03237cfe871ca7341f0bc40542 | 411 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 144 | 194 | 3.9E-13 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/116403|m.24526 | UnnamedSample_HQ_transcript/116403 | Coverage 0.858 too low. | f8815e042fe0b6436f5de61cdc39a9f7 | 223 | Pfam | PF01576 | Myosin tail | 2 | 187 | 2.1E-22 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/74739|m.18783 | UnnamedSample_HQ_transcript/74739 | Coverage 0.722 too low. | 94cb94a59ad27ed5add79735ce26b184 | 373 | Pfam | PF00651 | BTB/POZ domain | 203 | 308 | 1.2E-22 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/35490|m.10813 | UnnamedSample_HQ_transcript/35490 | Coverage 0.894 too low. | a528557d442c895e37719bde93f66b2b | 274 | Pfam | PF00083 | Sugar (and other) transporter | 22 | 249 | 2.2E-29 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/18110|m.6334 | UnnamedSample_HQ_transcript/18110 | Coverage 0.124 too low. | 65599339972ee89f63e7a31a03b7337a | 995 | Pfam | PF11838 | ERAP1-like C-terminal domain | 592 | 897 | 4.1E-58 | T | 22-09-2020 | IPR024571 | ERAP1-like C-terminal domain |
| UnnamedSample_HQ_transcript/18110|m.6334 | UnnamedSample_HQ_transcript/18110 | Coverage 0.124 too low. | 65599339972ee89f63e7a31a03b7337a | 995 | Pfam | PF01433 | Peptidase family M1 domain | 282 | 511 | 5.3E-64 | T | 22-09-2020 | IPR014782 | Peptidase M1, membrane alanine aminopeptidase |
| UnnamedSample_HQ_transcript/18110|m.6334 | UnnamedSample_HQ_transcript/18110 | Coverage 0.124 too low. | 65599339972ee89f63e7a31a03b7337a | 995 | Pfam | PF17900 | Peptidase M1 N-terminal domain | 65 | 250 | 3.2E-48 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/99753|m.22599 | UnnamedSample_HQ_transcript/99753 | Coverage 0.148 too low. | 692c4c6129e6eefae66313106e5abe42 | 336 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 33 | 122 | 4.1E-31 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/99753|m.22599 | UnnamedSample_HQ_transcript/99753 | Coverage 0.148 too low. | 692c4c6129e6eefae66313106e5abe42 | 336 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 151 | 236 | 2.3E-13 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/17197|m.6068 | UnnamedSample_HQ_transcript/17197 | Coverage 0.904 too low. | 4145c167657c0385f958805706912f06 | 1134 | Pfam | PF07534 | TLD | 998 | 1133 | 3.9E-33 | T | 22-09-2020 | IPR006571 | TLDc domain |
| UnnamedSample_HQ_transcript/17197|m.6068 | UnnamedSample_HQ_transcript/17197 | Coverage 0.904 too low. | 4145c167657c0385f958805706912f06 | 1134 | Pfam | PF01476 | LysM domain | 190 | 232 | 8.6E-9 | T | 22-09-2020 | IPR018392 | LysM domain |
| UnnamedSample_HQ_transcript/4185|m.1878 | UnnamedSample_HQ_transcript/4185 | Identity 0.851 too low. | 8ecf7660152085919922b1700e7c4d30 | 695 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 511 | 524 | 7.7 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/4185|m.1878 | UnnamedSample_HQ_transcript/4185 | Identity 0.851 too low. | 8ecf7660152085919922b1700e7c4d30 | 695 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 428 | 442 | 7 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/4185|m.1878 | UnnamedSample_HQ_transcript/4185 | Identity 0.851 too low. | 8ecf7660152085919922b1700e7c4d30 | 695 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 471 | 483 | 30 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/4185|m.1878 | UnnamedSample_HQ_transcript/4185 | Identity 0.851 too low. | 8ecf7660152085919922b1700e7c4d30 | 695 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 675 | 688 | 4.1 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/4185|m.1878 | UnnamedSample_HQ_transcript/4185 | Identity 0.851 too low. | 8ecf7660152085919922b1700e7c4d30 | 695 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 180 | 201 | 25 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/4185|m.1878 | UnnamedSample_HQ_transcript/4185 | Identity 0.851 too low. | 8ecf7660152085919922b1700e7c4d30 | 695 | Pfam | PF07671 | Protein of unknown function (DUF1601) | 252 | 266 | 11 | T | 22-09-2020 | IPR011632 | Domain of unknown function DUF1601 |
| UnnamedSample_HQ_transcript/107586|m.23537 | UnnamedSample_HQ_transcript/107586 | Identity 0.940 too low. | 5275fc0125e36b7007ef0d49d5d9d130 | 220 | Pfam | PF02921 | Ubiquinol cytochrome reductase transmembrane region | 25 | 84 | 5.9E-17 | T | 22-09-2020 | IPR004192 | Cytochrome b-c1 complex subunit Rieske, transmembrane domain |
| UnnamedSample_HQ_transcript/107586|m.23537 | UnnamedSample_HQ_transcript/107586 | Identity 0.940 too low. | 5275fc0125e36b7007ef0d49d5d9d130 | 220 | Pfam | PF00355 | Rieske [2Fe-2S] domain | 103 | 208 | 6.0E-12 | T | 22-09-2020 | IPR017941 | Rieske [2Fe-2S] iron-sulphur domain |
| UnnamedSample_HQ_transcript/111968|m.24074 | UnnamedSample_HQ_transcript/111968 | Identity 0.937 too low. | 5275fc0125e36b7007ef0d49d5d9d130 | 220 | Pfam | PF02921 | Ubiquinol cytochrome reductase transmembrane region | 25 | 84 | 5.9E-17 | T | 22-09-2020 | IPR004192 | Cytochrome b-c1 complex subunit Rieske, transmembrane domain |
| UnnamedSample_HQ_transcript/111968|m.24074 | UnnamedSample_HQ_transcript/111968 | Identity 0.937 too low. | 5275fc0125e36b7007ef0d49d5d9d130 | 220 | Pfam | PF00355 | Rieske [2Fe-2S] domain | 103 | 208 | 6.0E-12 | T | 22-09-2020 | IPR017941 | Rieske [2Fe-2S] iron-sulphur domain |
| UnnamedSample_HQ_transcript/7639|m.3067 | UnnamedSample_HQ_transcript/7639 | Coverage 0.154 too low. | 09acc9d0459522d6ddf38c1e2ab3971c | 1006 | Pfam | PF08447 | PAS fold | 247 | 332 | 9.8E-15 | T | 22-09-2020 | IPR013655 | PAS fold-3 |
| UnnamedSample_HQ_transcript/7639|m.3067 | UnnamedSample_HQ_transcript/7639 | Coverage 0.154 too low. | 09acc9d0459522d6ddf38c1e2ab3971c | 1006 | Pfam | PF00989 | PAS fold | 80 | 139 | 1.1E-9 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/3783|m.1728 | UnnamedSample_HQ_transcript/3783 | Coverage 0.205 too low. | b3a6cbe3a84f0a55f8eabdf5504e93ad | 1175 | Pfam | PF00439 | Bromodomain | 222 | 302 | 4.9E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/26055|m.8491 | UnnamedSample_HQ_transcript/26055 | Coverage 0.249 too low. | d68b8941524cd12aa0901bb006ed64cf | 595 | Pfam | PF00929 | Exonuclease | 430 | 581 | 2.6E-6 | T | 22-09-2020 | IPR013520 | Exonuclease, RNase T/DNA polymerase III |
| UnnamedSample_HQ_transcript/51452|m.14342 | UnnamedSample_HQ_transcript/51452 | Coverage 0.334 too low. | d68b8941524cd12aa0901bb006ed64cf | 595 | Pfam | PF00929 | Exonuclease | 430 | 581 | 2.6E-6 | T | 22-09-2020 | IPR013520 | Exonuclease, RNase T/DNA polymerase III |
| UnnamedSample_HQ_transcript/24714|m.8136 | UnnamedSample_HQ_transcript/24714 | Coverage 0.278 too low. | d68b8941524cd12aa0901bb006ed64cf | 595 | Pfam | PF00929 | Exonuclease | 430 | 581 | 2.6E-6 | T | 22-09-2020 | IPR013520 | Exonuclease, RNase T/DNA polymerase III |
| UnnamedSample_HQ_transcript/30958|m.9702 | UnnamedSample_HQ_transcript/30958 | Coverage 0.214 too low. | d68b8941524cd12aa0901bb006ed64cf | 595 | Pfam | PF00929 | Exonuclease | 430 | 581 | 2.6E-6 | T | 22-09-2020 | IPR013520 | Exonuclease, RNase T/DNA polymerase III |
| UnnamedSample_HQ_transcript/31309|m.9790 | UnnamedSample_HQ_transcript/31309 | Coverage 0.265 too low. | d68b8941524cd12aa0901bb006ed64cf | 595 | Pfam | PF00929 | Exonuclease | 430 | 581 | 2.6E-6 | T | 22-09-2020 | IPR013520 | Exonuclease, RNase T/DNA polymerase III |
| UnnamedSample_HQ_transcript/38825|m.11583 | UnnamedSample_HQ_transcript/38825 | Coverage 0.979 too low. | 3c35519f0176b5d13e4f106d63bd1528 | 151 | Pfam | PF00053 | Laminin EGF domain | 2 | 33 | 3.7E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/32486|m.10076 | UnnamedSample_HQ_transcript/32486 | Coverage 0.175 too low. | e5340d71fe5d3e2625ae9abd90db323d | 628 | Pfam | PF13894 | C2H2-type zinc finger | 347 | 368 | 6.9E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/32486|m.10076 | UnnamedSample_HQ_transcript/32486 | Coverage 0.175 too low. | e5340d71fe5d3e2625ae9abd90db323d | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 597 | 618 | 4.7E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/32486|m.10076 | UnnamedSample_HQ_transcript/32486 | Coverage 0.175 too low. | e5340d71fe5d3e2625ae9abd90db323d | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 484 | 506 | 2.5E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/32486|m.10076 | UnnamedSample_HQ_transcript/32486 | Coverage 0.175 too low. | e5340d71fe5d3e2625ae9abd90db323d | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 234 | 256 | 2.0E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/32486|m.10076 | UnnamedSample_HQ_transcript/32486 | Coverage 0.175 too low. | e5340d71fe5d3e2625ae9abd90db323d | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 568 | 590 | 6.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/32486|m.10076 | UnnamedSample_HQ_transcript/32486 | Coverage 0.175 too low. | e5340d71fe5d3e2625ae9abd90db323d | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 428 | 450 | 3.1E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/32486|m.10076 | UnnamedSample_HQ_transcript/32486 | Coverage 0.175 too low. | e5340d71fe5d3e2625ae9abd90db323d | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 290 | 312 | 0.0012 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/32486|m.10076 | UnnamedSample_HQ_transcript/32486 | Coverage 0.175 too low. | e5340d71fe5d3e2625ae9abd90db323d | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 512 | 534 | 4.5E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/32486|m.10076 | UnnamedSample_HQ_transcript/32486 | Coverage 0.175 too low. | e5340d71fe5d3e2625ae9abd90db323d | 628 | Pfam | PF00096 | Zinc finger, C2H2 type | 374 | 396 | 0.0014 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/4860|m.2138 | UnnamedSample_HQ_transcript/4860 | Coverage 0.909 too low. | c5c98eee86bc992927b77f07ac5a94c3 | 1039 | Pfam | PF00620 | RhoGAP domain | 456 | 600 | 2.9E-32 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/4860|m.2138 | UnnamedSample_HQ_transcript/4860 | Coverage 0.909 too low. | c5c98eee86bc992927b77f07ac5a94c3 | 1039 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 297 | 373 | 5.2E-5 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/90051|m.21264 | UnnamedSample_HQ_transcript/90051 | Coverage 0.118 too low. | ebd84e80510eb4b4e3ef882c398ee7bb | 392 | Pfam | PF00515 | Tetratricopeptide repeat | 341 | 373 | 5.2E-7 | T | 22-09-2020 | IPR001440 | Tetratricopeptide repeat 1 |
| UnnamedSample_HQ_transcript/90051|m.21264 | UnnamedSample_HQ_transcript/90051 | Coverage 0.118 too low. | ebd84e80510eb4b4e3ef882c398ee7bb | 392 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 33 | 122 | 5.4E-31 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/90051|m.21264 | UnnamedSample_HQ_transcript/90051 | Coverage 0.118 too low. | ebd84e80510eb4b4e3ef882c398ee7bb | 392 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 151 | 236 | 3.0E-13 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/85193|m.20524 | UnnamedSample_HQ_transcript/85193 | Coverage 0.201 too low. | ebd84e80510eb4b4e3ef882c398ee7bb | 392 | Pfam | PF00515 | Tetratricopeptide repeat | 341 | 373 | 5.2E-7 | T | 22-09-2020 | IPR001440 | Tetratricopeptide repeat 1 |
| UnnamedSample_HQ_transcript/85193|m.20524 | UnnamedSample_HQ_transcript/85193 | Coverage 0.201 too low. | ebd84e80510eb4b4e3ef882c398ee7bb | 392 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 33 | 122 | 5.4E-31 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/85193|m.20524 | UnnamedSample_HQ_transcript/85193 | Coverage 0.201 too low. | ebd84e80510eb4b4e3ef882c398ee7bb | 392 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 151 | 236 | 3.0E-13 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/94334|m.21851 | UnnamedSample_HQ_transcript/94334 | Coverage 0.076 too low. | ebd84e80510eb4b4e3ef882c398ee7bb | 392 | Pfam | PF00515 | Tetratricopeptide repeat | 341 | 373 | 5.2E-7 | T | 22-09-2020 | IPR001440 | Tetratricopeptide repeat 1 |
| UnnamedSample_HQ_transcript/94334|m.21851 | UnnamedSample_HQ_transcript/94334 | Coverage 0.076 too low. | ebd84e80510eb4b4e3ef882c398ee7bb | 392 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 33 | 122 | 5.4E-31 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/94334|m.21851 | UnnamedSample_HQ_transcript/94334 | Coverage 0.076 too low. | ebd84e80510eb4b4e3ef882c398ee7bb | 392 | Pfam | PF00254 | FKBP-type peptidyl-prolyl cis-trans isomerase | 151 | 236 | 3.0E-13 | T | 22-09-2020 | IPR001179 | FKBP-type peptidyl-prolyl cis-trans isomerase domain |
| UnnamedSample_HQ_transcript/5318|m.2305 | UnnamedSample_HQ_transcript/5318 | Coverage 0.983 too low. | 2dd593005022dd8240d1816379337259 | 660 | Pfam | PF00850 | Histone deacetylase domain | 257 | 564 | 2.4E-80 | T | 22-09-2020 | IPR023801 | Histone deacetylase domain |
| UnnamedSample_HQ_transcript/91668|m.21494 | UnnamedSample_HQ_transcript/91668 | Coverage 0.710 too low. | 945b4c8ddc61099b4740cdcafa2c9910 | 378 | Pfam | PF00204 | DNA gyrase B | 268 | 378 | 1.5E-20 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/91668|m.21494 | UnnamedSample_HQ_transcript/91668 | Coverage 0.710 too low. | 945b4c8ddc61099b4740cdcafa2c9910 | 378 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 81 | 225 | 1.6E-16 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/22166|m.7473 | UnnamedSample_HQ_transcript/22166 | Coverage 0.061 too low. | 992dd3351f63a2ef8bcc98ae56ef5e52 | 916 | Pfam | PF13086 | AAA domain | 812 | 877 | 6.1E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/22166|m.7473 | UnnamedSample_HQ_transcript/22166 | Coverage 0.061 too low. | 992dd3351f63a2ef8bcc98ae56ef5e52 | 916 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 43 | 412 | 9.6E-10 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/72174|m.18332 | UnnamedSample_HQ_transcript/72174 | Coverage 0.770 too low. | 62a66d8492ae7b3836b44a41d7537e06 | 400 | Pfam | PF01546 | Peptidase family M20/M25/M40 | 75 | 396 | 1.3E-40 | T | 22-09-2020 | IPR002933 | Peptidase M20 |
| UnnamedSample_HQ_transcript/72174|m.18332 | UnnamedSample_HQ_transcript/72174 | Coverage 0.770 too low. | 62a66d8492ae7b3836b44a41d7537e06 | 400 | Pfam | PF07687 | Peptidase dimerisation domain | 187 | 297 | 5.1E-11 | T | 22-09-2020 | IPR011650 | Peptidase M20, dimerisation domain |
| UnnamedSample_HQ_transcript/78492|m.19460 | UnnamedSample_HQ_transcript/78492 | Coverage 0.832 too low. | 62a66d8492ae7b3836b44a41d7537e06 | 400 | Pfam | PF01546 | Peptidase family M20/M25/M40 | 75 | 396 | 1.3E-40 | T | 22-09-2020 | IPR002933 | Peptidase M20 |
| UnnamedSample_HQ_transcript/78492|m.19460 | UnnamedSample_HQ_transcript/78492 | Coverage 0.832 too low. | 62a66d8492ae7b3836b44a41d7537e06 | 400 | Pfam | PF07687 | Peptidase dimerisation domain | 187 | 297 | 5.1E-11 | T | 22-09-2020 | IPR011650 | Peptidase M20, dimerisation domain |
| UnnamedSample_HQ_transcript/26324|m.8561 | UnnamedSample_HQ_transcript/26324 | Coverage 0.597 too low. | c5e640e162be60c4577af3b089b6c402 | 160 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 1 | 27 | 1.9E-7 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/26324|m.8561 | UnnamedSample_HQ_transcript/26324 | Coverage 0.597 too low. | c5e640e162be60c4577af3b089b6c402 | 160 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 32 | 65 | 5.4E-12 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/26324|m.8561 | UnnamedSample_HQ_transcript/26324 | Coverage 0.597 too low. | c5e640e162be60c4577af3b089b6c402 | 160 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 68 | 98 | 6.4E-7 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 1094 | 1149 | 1.7E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 1152 | 1202 | 3.4E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 3 | 35 | 1.7E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 1205 | 1249 | 3.0E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 710 | 754 | 1.9E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 1299 | 1338 | 4.6E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 1252 | 1296 | 3.5E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 1044 | 1091 | 5.6E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 758 | 806 | 2.4E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 38 | 70 | 4.1E-6 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 619 | 667 | 4.8E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00053 | Laminin EGF domain | 1010 | 1034 | 1.9E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/2119|m.1101 | UnnamedSample_HQ_transcript/2119 | Coverage 0.724 too low. | 4ef53aa3f6241205364d625136343e34 | 1631 | Pfam | PF00052 | Laminin B (Domain IV) | 874 | 1009 | 8.0E-23 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/28912|m.9204 | UnnamedSample_HQ_transcript/28912 | Coverage 0.975 too low. | 30fbb85e33f94416cc9eece174e65da0 | 745 | Pfam | PF02347 | Glycine cleavage system P-protein | 1 | 353 | 3.3E-151 | T | 22-09-2020 | IPR020581 | Glycine cleavage system P protein |
| UnnamedSample_HQ_transcript/28912|m.9204 | UnnamedSample_HQ_transcript/28912 | Coverage 0.975 too low. | 30fbb85e33f94416cc9eece174e65da0 | 745 | Pfam | PF02347 | Glycine cleavage system P-protein | 389 | 659 | 4.3E-8 | T | 22-09-2020 | IPR020581 | Glycine cleavage system P protein |
| UnnamedSample_HQ_transcript/31893|m.9922 | UnnamedSample_HQ_transcript/31893 | Coverage 0.176 too low. | d81b1e9b994bcc9d6d67264d2ac8e1f3 | 669 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 198 | 281 | 2.5E-9 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/31893|m.9922 | UnnamedSample_HQ_transcript/31893 | Coverage 0.176 too low. | d81b1e9b994bcc9d6d67264d2ac8e1f3 | 669 | Pfam | PF00169 | PH domain | 327 | 432 | 1.3E-9 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/56925|m.15427 | UnnamedSample_HQ_transcript/56925 | Coverage 0.406 too low. | b69a843c5bfa382dc8121bdf7ea226f8 | 350 | Pfam | PF01496 | V-type ATPase 116kDa subunit family | 28 | 344 | 2.0E-99 | T | 22-09-2020 | IPR002490 | V-type ATPase, V0 complex, 116kDa subunit family |
| UnnamedSample_HQ_transcript/60636|m.16187 | UnnamedSample_HQ_transcript/60636 | Coverage 0.883 too low. | 33631496a927bcb86a56a3b0616c5989 | 563 | Pfam | PF16013 | Domain of unknown function (DUF4781) | 111 | 341 | 3.1E-42 | T | 22-09-2020 | IPR031962 | Domain of unknown function DUF4781 |
| UnnamedSample_HQ_transcript/57656|m.15581 | UnnamedSample_HQ_transcript/57656 | Unmapped. | 09b1caa7db499184c175301e2531fcba | 583 | Pfam | PF13087 | AAA domain | 435 | 553 | 4.6E-11 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/57656|m.15581 | UnnamedSample_HQ_transcript/57656 | Unmapped. | 09b1caa7db499184c175301e2531fcba | 583 | Pfam | PF13086 | AAA domain | 252 | 322 | 2.1E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/23597|m.7832 | UnnamedSample_HQ_transcript/23597 | Identity 0.778 too low. | 5b38c26e0293aba0a2f4699a805f04d7 | 602 | Pfam | PF01204 | Trehalase | 55 | 567 | 4.8E-150 | T | 22-09-2020 | IPR001661 | Glycoside hydrolase, family 37 |
| UnnamedSample_HQ_transcript/40464|m.11955 | UnnamedSample_HQ_transcript/40464 | Identity 0.733 too low. | 5b38c26e0293aba0a2f4699a805f04d7 | 602 | Pfam | PF01204 | Trehalase | 55 | 567 | 4.8E-150 | T | 22-09-2020 | IPR001661 | Glycoside hydrolase, family 37 |
| UnnamedSample_HQ_transcript/49633|m.13939 | UnnamedSample_HQ_transcript/49633 | Identity 0.938 too low. | 5b38c26e0293aba0a2f4699a805f04d7 | 602 | Pfam | PF01204 | Trehalase | 55 | 567 | 4.8E-150 | T | 22-09-2020 | IPR001661 | Glycoside hydrolase, family 37 |
| UnnamedSample_HQ_transcript/31564|m.9846 | UnnamedSample_HQ_transcript/31564 | Coverage 0.735 too low. | 5768d831f1a6fee12f6b0f18695ee65e | 809 | Pfam | PF02187 | Growth-Arrest-Specific Protein 2 Domain | 225 | 293 | 2.2E-34 | T | 22-09-2020 | IPR003108 | GAR domain |
| UnnamedSample_HQ_transcript/31564|m.9846 | UnnamedSample_HQ_transcript/31564 | Coverage 0.735 too low. | 5768d831f1a6fee12f6b0f18695ee65e | 809 | Pfam | PF00307 | Calponin homology (CH) domain | 23 | 155 | 6.2E-12 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/1773|m.968 | UnnamedSample_HQ_transcript/1773 | Coverage 0.348 too low. | 8db5d8bac9fd73f99631d92f7e8f5d8b | 1371 | Pfam | PF19056 | WD40 repeated domain | 993 | 1208 | 6.1E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/1773|m.968 | UnnamedSample_HQ_transcript/1773 | Coverage 0.348 too low. | 8db5d8bac9fd73f99631d92f7e8f5d8b | 1371 | Pfam | PF09744 | JNK_SAPK-associated protein-1 | 21 | 175 | 1.8E-52 | T | 22-09-2020 | IPR019143 | JNK/Rab-associated protein-1, N-terminal |
| UnnamedSample_HQ_transcript/1773|m.968 | UnnamedSample_HQ_transcript/1773 | Coverage 0.348 too low. | 8db5d8bac9fd73f99631d92f7e8f5d8b | 1371 | Pfam | PF16471 | JNK-interacting protein leucine zipper II | 369 | 438 | 7.6E-31 | T | 22-09-2020 | IPR032486 | JNK-interacting protein, leucine zipper II |
| UnnamedSample_HQ_transcript/40476|m.11956 | UnnamedSample_HQ_transcript/40476 | Coverage 0.826 too low. | b67b260ea951a7629e2f9a9cffb3f0f4 | 712 | Pfam | PF00096 | Zinc finger, C2H2 type | 688 | 708 | 0.0019 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/40476|m.11956 | UnnamedSample_HQ_transcript/40476 | Coverage 0.826 too low. | b67b260ea951a7629e2f9a9cffb3f0f4 | 712 | Pfam | PF00096 | Zinc finger, C2H2 type | 632 | 654 | 2.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/40476|m.11956 | UnnamedSample_HQ_transcript/40476 | Coverage 0.826 too low. | b67b260ea951a7629e2f9a9cffb3f0f4 | 712 | Pfam | PF00096 | Zinc finger, C2H2 type | 604 | 626 | 0.0042 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/78105|m.19390 | UnnamedSample_HQ_transcript/78105 | Unmapped. | 8d2844706804484c887c9402d22ff935 | 422 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 265 | 6.3E-7 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/86011|m.20655 | UnnamedSample_HQ_transcript/86011 | Unmapped. | 8d2844706804484c887c9402d22ff935 | 422 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 265 | 6.3E-7 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/9888|m.3790 | UnnamedSample_HQ_transcript/9888 | Coverage 0.989 too low. | 99a128e22c3f87429df8cc2bbe58dde0 | 832 | Pfam | PF02828 | L27 domain | 342 | 394 | 9.9E-7 | T | 22-09-2020 | IPR014775 | L27 domain, C-terminal |
| UnnamedSample_HQ_transcript/9888|m.3790 | UnnamedSample_HQ_transcript/9888 | Coverage 0.989 too low. | 99a128e22c3f87429df8cc2bbe58dde0 | 832 | Pfam | PF00018 | SH3 domain | 528 | 582 | 7.2E-8 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/9888|m.3790 | UnnamedSample_HQ_transcript/9888 | Coverage 0.989 too low. | 99a128e22c3f87429df8cc2bbe58dde0 | 832 | Pfam | PF00595 | PDZ domain | 435 | 511 | 2.3E-14 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/9888|m.3790 | UnnamedSample_HQ_transcript/9888 | Coverage 0.989 too low. | 99a128e22c3f87429df8cc2bbe58dde0 | 832 | Pfam | PF00625 | Guanylate kinase | 645 | 817 | 2.2E-55 | T | 22-09-2020 | IPR008145 | Guanylate kinase/L-type calcium channel beta subunit |
| UnnamedSample_HQ_transcript/9888|m.3790 | UnnamedSample_HQ_transcript/9888 | Coverage 0.989 too low. | 99a128e22c3f87429df8cc2bbe58dde0 | 832 | Pfam | PF00069 | Protein kinase domain | 2 | 210 | 1.1E-54 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/50260|m.14074 | UnnamedSample_HQ_transcript/50260 | Coverage 0.573 too low. | 03e106889dad438ed9811d9396bf9eba | 541 | Pfam | PF01476 | LysM domain | 219 | 261 | 3.5E-9 | T | 22-09-2020 | IPR018392 | LysM domain |
| UnnamedSample_HQ_transcript/96585|m.22175 | UnnamedSample_HQ_transcript/96585 | Identity 0.398 too low. | 2df81c2da1017e2804a9e419bfeda606 | 199 | Pfam | PF00567 | Tudor domain | 42 | 151 | 4.7E-19 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/21549|m.7293 | UnnamedSample_HQ_transcript/21549 | Unmapped. | 56409584d70f1ef52a8df8a4b0c42e97 | 866 | Pfam | PF00856 | SET domain | 32 | 135 | 6.5E-8 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/21549|m.7293 | UnnamedSample_HQ_transcript/21549 | Unmapped. | 56409584d70f1ef52a8df8a4b0c42e97 | 866 | Pfam | PF02902 | Ulp1 protease family, C-terminal catalytic domain | 718 | 857 | 5.4E-13 | T | 22-09-2020 | IPR003653 | Ulp1 protease family, C-terminal catalytic domain |
| UnnamedSample_HQ_transcript/26805|m.8677 | UnnamedSample_HQ_transcript/26805 | Unmapped. | 56409584d70f1ef52a8df8a4b0c42e97 | 866 | Pfam | PF00856 | SET domain | 32 | 135 | 6.5E-8 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/26805|m.8677 | UnnamedSample_HQ_transcript/26805 | Unmapped. | 56409584d70f1ef52a8df8a4b0c42e97 | 866 | Pfam | PF02902 | Ulp1 protease family, C-terminal catalytic domain | 718 | 857 | 5.4E-13 | T | 22-09-2020 | IPR003653 | Ulp1 protease family, C-terminal catalytic domain |
| UnnamedSample_HQ_transcript/2576|m.1262 | UnnamedSample_HQ_transcript/2576 | Unmapped. | 9b512b9f0574e0e559a15596a53125af | 1704 | Pfam | PF00270 | DEAD/DEAH box helicase | 1345 | 1477 | 6.6E-9 | T | 22-09-2020 | IPR011545 | DEAD/DEAH box helicase domain |
| UnnamedSample_HQ_transcript/44362|m.12784 | UnnamedSample_HQ_transcript/44362 | Coverage 0.323 too low. | ad99df6828c5a23ad83838d6082689fd | 727 | Pfam | PF13385 | Concanavalin A-like lectin/glucanases superfamily | 344 | 514 | 9.2E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/44362|m.12784 | UnnamedSample_HQ_transcript/44362 | Coverage 0.323 too low. | ad99df6828c5a23ad83838d6082689fd | 727 | Pfam | PF00028 | Cadherin domain | 147 | 232 | 3.6E-9 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/37812|m.11347 | UnnamedSample_HQ_transcript/37812 | Coverage 0.312 too low. | 352e73e3e231fd449fdfb6b7c6cefad9 | 319 | Pfam | PF15997 | Domain of unknown function (DUF4772) | 5 | 120 | 7.2E-34 | T | 22-09-2020 | IPR031940 | Domain of unknown function DUF4772 |
| UnnamedSample_HQ_transcript/78810|m.19519 | UnnamedSample_HQ_transcript/78810 | Coverage 0.980 too low. | a47087012b05a84dc47c6d2bd2f26009 | 184 | Pfam | PF01928 | CYTH domain | 10 | 170 | 6.6E-16 | T | 22-09-2020 | IPR023577 | CYTH domain |
| UnnamedSample_HQ_transcript/58867|m.15823 | UnnamedSample_HQ_transcript/58867 | Identity 0.896 too low. | a47087012b05a84dc47c6d2bd2f26009 | 184 | Pfam | PF01928 | CYTH domain | 10 | 170 | 6.6E-16 | T | 22-09-2020 | IPR023577 | CYTH domain |
| UnnamedSample_HQ_transcript/79069|m.19561 | UnnamedSample_HQ_transcript/79069 | Identity 0.901 too low. | a47087012b05a84dc47c6d2bd2f26009 | 184 | Pfam | PF01928 | CYTH domain | 10 | 170 | 6.6E-16 | T | 22-09-2020 | IPR023577 | CYTH domain |
| UnnamedSample_HQ_transcript/82751|m.20153 | UnnamedSample_HQ_transcript/82751 | Identity 0.776 too low. | a47087012b05a84dc47c6d2bd2f26009 | 184 | Pfam | PF01928 | CYTH domain | 10 | 170 | 6.6E-16 | T | 22-09-2020 | IPR023577 | CYTH domain |
| UnnamedSample_HQ_transcript/84482|m.20413 | UnnamedSample_HQ_transcript/84482 | Identity 0.800 too low. | a47087012b05a84dc47c6d2bd2f26009 | 184 | Pfam | PF01928 | CYTH domain | 10 | 170 | 6.6E-16 | T | 22-09-2020 | IPR023577 | CYTH domain |
| UnnamedSample_HQ_transcript/16200|m.5769 | UnnamedSample_HQ_transcript/16200 | Identity 0.874 too low. | a47087012b05a84dc47c6d2bd2f26009 | 184 | Pfam | PF01928 | CYTH domain | 10 | 170 | 6.6E-16 | T | 22-09-2020 | IPR023577 | CYTH domain |
| UnnamedSample_HQ_transcript/79879|m.19688 | UnnamedSample_HQ_transcript/79879 | Coverage 0.938 too low. | a47087012b05a84dc47c6d2bd2f26009 | 184 | Pfam | PF01928 | CYTH domain | 10 | 170 | 6.6E-16 | T | 22-09-2020 | IPR023577 | CYTH domain |
| UnnamedSample_HQ_transcript/95694|m.22049 | UnnamedSample_HQ_transcript/95694 | Coverage 0.846 too low. | a47087012b05a84dc47c6d2bd2f26009 | 184 | Pfam | PF01928 | CYTH domain | 10 | 170 | 6.6E-16 | T | 22-09-2020 | IPR023577 | CYTH domain |
| UnnamedSample_HQ_transcript/90312|m.21299 | UnnamedSample_HQ_transcript/90312 | Identity 0.890 too low. | a47087012b05a84dc47c6d2bd2f26009 | 184 | Pfam | PF01928 | CYTH domain | 10 | 170 | 6.6E-16 | T | 22-09-2020 | IPR023577 | CYTH domain |
| UnnamedSample_HQ_transcript/26472|m.8596 | UnnamedSample_HQ_transcript/26472 | Coverage 0.878 too low. | 62bfe51415c0e55b5d00049c9218d8aa | 867 | Pfam | PF07703 | Alpha-2-macroglobulin bait region domain | 467 | 602 | 1.7E-18 | T | 22-09-2020 | IPR011625 | Alpha-2-macroglobulin, bait region domain |
| UnnamedSample_HQ_transcript/26472|m.8596 | UnnamedSample_HQ_transcript/26472 | Coverage 0.878 too low. | 62bfe51415c0e55b5d00049c9218d8aa | 867 | Pfam | PF17789 | Macroglobulin domain MG4 | 363 | 447 | 7.1E-7 | T | 22-09-2020 | IPR040839 | Macroglobulin domain MG4 |
| UnnamedSample_HQ_transcript/26472|m.8596 | UnnamedSample_HQ_transcript/26472 | Coverage 0.878 too low. | 62bfe51415c0e55b5d00049c9218d8aa | 867 | Pfam | PF01835 | MG2 domain | 148 | 239 | 1.6E-16 | T | 22-09-2020 | IPR002890 | Macroglobulin domain |
| UnnamedSample_HQ_transcript/26472|m.8596 | UnnamedSample_HQ_transcript/26472 | Coverage 0.878 too low. | 62bfe51415c0e55b5d00049c9218d8aa | 867 | Pfam | PF00207 | Alpha-2-macroglobulin family | 710 | 801 | 2.0E-27 | T | 22-09-2020 | IPR001599 | Alpha-2-macroglobulin |
| UnnamedSample_HQ_transcript/26472|m.8596 | UnnamedSample_HQ_transcript/26472 | Coverage 0.878 too low. | 62bfe51415c0e55b5d00049c9218d8aa | 867 | Pfam | PF17791 | Macroglobulin domain MG3 | 241 | 289 | 8.6E-16 | T | 22-09-2020 | IPR041555 | Macroglobulin domain MG3 |
| UnnamedSample_HQ_transcript/68131|m.17605 | UnnamedSample_HQ_transcript/68131 | Coverage 0.263 too low. | c05086e53548e459fe025a771a36fbb0 | 526 | Pfam | PF01425 | Amidase | 63 | 505 | 2.0E-77 | T | 22-09-2020 | IPR023631 | Amidase signature domain |
| UnnamedSample_HQ_transcript/51386|m.14327 | UnnamedSample_HQ_transcript/51386 | Coverage 0.350 too low. | c05086e53548e459fe025a771a36fbb0 | 526 | Pfam | PF01425 | Amidase | 63 | 505 | 2.0E-77 | T | 22-09-2020 | IPR023631 | Amidase signature domain |
| UnnamedSample_HQ_transcript/61402|m.16339 | UnnamedSample_HQ_transcript/61402 | Coverage 0.270 too low. | c05086e53548e459fe025a771a36fbb0 | 526 | Pfam | PF01425 | Amidase | 63 | 505 | 2.0E-77 | T | 22-09-2020 | IPR023631 | Amidase signature domain |
| UnnamedSample_HQ_transcript/57353|m.15515 | UnnamedSample_HQ_transcript/57353 | Coverage 0.284 too low. | c05086e53548e459fe025a771a36fbb0 | 526 | Pfam | PF01425 | Amidase | 63 | 505 | 2.0E-77 | T | 22-09-2020 | IPR023631 | Amidase signature domain |
| UnnamedSample_HQ_transcript/62347|m.16515 | UnnamedSample_HQ_transcript/62347 | Coverage 0.254 too low. | c05086e53548e459fe025a771a36fbb0 | 526 | Pfam | PF01425 | Amidase | 63 | 505 | 2.0E-77 | T | 22-09-2020 | IPR023631 | Amidase signature domain |
| UnnamedSample_HQ_transcript/73845|m.18620 | UnnamedSample_HQ_transcript/73845 | Coverage 0.941 too low. | f2004619dc29d4febd4c595c9a8844e7 | 396 | Pfam | PF00083 | Sugar (and other) transporter | 6 | 364 | 1.9E-59 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/67864|m.17556 | UnnamedSample_HQ_transcript/67864 | Coverage 0.907 too low. | f2004619dc29d4febd4c595c9a8844e7 | 396 | Pfam | PF00083 | Sugar (and other) transporter | 6 | 364 | 1.9E-59 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/110052|m.23841 | UnnamedSample_HQ_transcript/110052 | Coverage 0.901 too low. | b08e41cbf80938195e7a57a2ea2f6a79 | 115 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 3 | 69 | 1.3E-7 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/77871|m.19351 | UnnamedSample_HQ_transcript/77871 | Coverage 0.862 too low. | e9784211277520bf05ca1fd890459ebd | 453 | Pfam | PF00096 | Zinc finger, C2H2 type | 345 | 367 | 4.0E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/77871|m.19351 | UnnamedSample_HQ_transcript/77871 | Coverage 0.862 too low. | e9784211277520bf05ca1fd890459ebd | 453 | Pfam | PF00096 | Zinc finger, C2H2 type | 401 | 423 | 0.0062 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/77871|m.19351 | UnnamedSample_HQ_transcript/77871 | Coverage 0.862 too low. | e9784211277520bf05ca1fd890459ebd | 453 | Pfam | PF00096 | Zinc finger, C2H2 type | 373 | 395 | 2.3E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/82383|m.20093 | UnnamedSample_HQ_transcript/82383 | Coverage 0.854 too low. | 065ce70ef69dbf3e35b3904781ca6c1f | 363 | Pfam | PF10324 | Serpentine type 7TM GPCR chemoreceptor Srw | 29 | 328 | 7.9E-23 | T | 22-09-2020 | IPR019427 | 7TM GPCR, serpentine receptor class w (Srw) |
| UnnamedSample_HQ_transcript/46110|m.13165 | UnnamedSample_HQ_transcript/46110 | Coverage 0.676 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 250 | 498 | 5.4E-99 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/46110|m.13165 | UnnamedSample_HQ_transcript/46110 | Coverage 0.676 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00018 | SH3 domain | 71 | 118 | 7.1E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/46110|m.13165 | UnnamedSample_HQ_transcript/46110 | Coverage 0.676 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00017 | SH2 domain | 132 | 209 | 2.0E-26 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/25267|m.8279 | UnnamedSample_HQ_transcript/25267 | Coverage 0.520 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 250 | 498 | 5.4E-99 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/25267|m.8279 | UnnamedSample_HQ_transcript/25267 | Coverage 0.520 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00018 | SH3 domain | 71 | 118 | 7.1E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/25267|m.8279 | UnnamedSample_HQ_transcript/25267 | Coverage 0.520 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00017 | SH2 domain | 132 | 209 | 2.0E-26 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/64207|m.16889 | UnnamedSample_HQ_transcript/64207 | Coverage 0.823 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 250 | 498 | 5.4E-99 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/64207|m.16889 | UnnamedSample_HQ_transcript/64207 | Coverage 0.823 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00018 | SH3 domain | 71 | 118 | 7.1E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/64207|m.16889 | UnnamedSample_HQ_transcript/64207 | Coverage 0.823 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00017 | SH2 domain | 132 | 209 | 2.0E-26 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/14752|m.5342 | UnnamedSample_HQ_transcript/14752 | Coverage 0.431 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 250 | 498 | 5.4E-99 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/14752|m.5342 | UnnamedSample_HQ_transcript/14752 | Coverage 0.431 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00018 | SH3 domain | 71 | 118 | 7.1E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/14752|m.5342 | UnnamedSample_HQ_transcript/14752 | Coverage 0.431 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00017 | SH2 domain | 132 | 209 | 2.0E-26 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/23013|m.7695 | UnnamedSample_HQ_transcript/23013 | Coverage 0.499 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 250 | 498 | 5.4E-99 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/23013|m.7695 | UnnamedSample_HQ_transcript/23013 | Coverage 0.499 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00018 | SH3 domain | 71 | 118 | 7.1E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/23013|m.7695 | UnnamedSample_HQ_transcript/23013 | Coverage 0.499 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00017 | SH2 domain | 132 | 209 | 2.0E-26 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/11719|m.4400 | UnnamedSample_HQ_transcript/11719 | Coverage 0.416 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 250 | 498 | 5.4E-99 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/11719|m.4400 | UnnamedSample_HQ_transcript/11719 | Coverage 0.416 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00018 | SH3 domain | 71 | 118 | 7.1E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/11719|m.4400 | UnnamedSample_HQ_transcript/11719 | Coverage 0.416 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00017 | SH2 domain | 132 | 209 | 2.0E-26 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/14401|m.5234 | UnnamedSample_HQ_transcript/14401 | Coverage 0.395 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 250 | 498 | 5.4E-99 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/14401|m.5234 | UnnamedSample_HQ_transcript/14401 | Coverage 0.395 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00018 | SH3 domain | 71 | 118 | 7.1E-18 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/14401|m.5234 | UnnamedSample_HQ_transcript/14401 | Coverage 0.395 too low. | 60e168f1a2d9e31c982e0043f1653b34 | 516 | Pfam | PF00017 | SH2 domain | 132 | 209 | 2.0E-26 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/87392|m.20856 | UnnamedSample_HQ_transcript/87392 | Identity 0.769 too low. | 414096dbfc10500504573d2c0712a910 | 321 | Pfam | PF08450 | SMP-30/Gluconolactonase/LRE-like region | 14 | 281 | 4.1E-62 | T | 22-09-2020 | IPR013658 | SMP-30/Gluconolactonase/LRE-like region |
| UnnamedSample_HQ_transcript/89074|m.21095 | UnnamedSample_HQ_transcript/89074 | Identity 0.762 too low. | 414096dbfc10500504573d2c0712a910 | 321 | Pfam | PF08450 | SMP-30/Gluconolactonase/LRE-like region | 14 | 281 | 4.1E-62 | T | 22-09-2020 | IPR013658 | SMP-30/Gluconolactonase/LRE-like region |
| UnnamedSample_HQ_transcript/14969|m.5392 | UnnamedSample_HQ_transcript/14969 | Identity 0.915 too low. | 5973ce3996069727b5576182c583e107 | 977 | Pfam | PF00567 | Tudor domain | 791 | 871 | 6.4E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/14969|m.5392 | UnnamedSample_HQ_transcript/14969 | Identity 0.915 too low. | 5973ce3996069727b5576182c583e107 | 977 | Pfam | PF00567 | Tudor domain | 588 | 696 | 8.9E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/14969|m.5392 | UnnamedSample_HQ_transcript/14969 | Identity 0.915 too low. | 5973ce3996069727b5576182c583e107 | 977 | Pfam | PF00567 | Tudor domain | 381 | 491 | 2.0E-7 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/33860|m.10423 | UnnamedSample_HQ_transcript/33860 | Coverage 0.983 too low. | e4de5e54c3cd8925daa97122c988e543 | 707 | Pfam | PF00520 | Ion transport protein | 362 | 587 | 1.7E-8 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/106084|m.23343 | UnnamedSample_HQ_transcript/106084 | Coverage 0.955 too low. | 5e1b9ccd6a1789476d0da079d9d3dfd7 | 205 | Pfam | PF13460 | NAD(P)H-binding | 8 | 189 | 3.8E-31 | T | 22-09-2020 | IPR016040 | NAD(P)-binding domain |
| UnnamedSample_HQ_transcript/87764|m.20900 | UnnamedSample_HQ_transcript/87764 | Coverage 0.940 too low. | cf1df44eec8dd917dbe14db2a3af88f7 | 232 | Pfam | PF10222 | Uncharacterized conserved protein (DUF2152) | 1 | 210 | 8.8E-107 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/29294|m.9304 | UnnamedSample_HQ_transcript/29294 | Coverage 0.877 too low. | 87749447621eb1f1ce4c4cc5cc53200d | 376 | Pfam | PF03567 | Sulfotransferase family | 101 | 361 | 1.2E-21 | T | 22-09-2020 | IPR005331 | Sulfotransferase |
| UnnamedSample_HQ_transcript/11927|m.4475 | UnnamedSample_HQ_transcript/11927 | Coverage 0.713 too low. | 3d548fb3e0427936fb20c8bbdf1e095a | 342 | Pfam | PF00652 | Ricin-type beta-trefoil lectin domain | 270 | 340 | 2.2E-13 | T | 22-09-2020 | IPR000772 | Ricin B, lectin domain |
| UnnamedSample_HQ_transcript/11927|m.4475 | UnnamedSample_HQ_transcript/11927 | Coverage 0.713 too low. | 3d548fb3e0427936fb20c8bbdf1e095a | 342 | Pfam | PF00535 | Glycosyl transferase family 2 | 4 | 143 | 3.6E-20 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
